Mindtrix

Based in Suzhou, China and founded in 2024, Mindtrix Technology (Suzhou) Co. , Ltd. , doing business as Mindtrix, is a company engaged in brain-computer interface technology, providing clinical-grade data for visual reconstruction. The company has established subsidiaries in Beijing and Shanghai, China.

In April 2026, Mindtrix closed two rounds of angel+ and angel++ funding from Huafang Capital, Delian Capital, HighLight Capital, Hengxu Capital, Rising Investments, Lynnovest, and other investors. The two deals were part of a larger CNY 150 million angel funding. Mindtrix develops comprehensive solutions that include software, hardware, algorithms, training paradigms and devices based on minimally invasive implantation, flexible materials, large-scale recording and stimulation and semi or full implantation systems. The company's solutions have applications in visual restoration and other neural system dysfunction such as depression and Parkinson disease.

The company generates revenue from developing brain-computer interface technology focusing on visual restoration and motor control for functional impaired patients. The company will use the angel funding to accelerate the visual reconstruction brain-computer interface technology toward a clinically verifiable product stage, laying a solid technical and clinical data foundation for conducting registration clinical trials, and further consolidating the company's position in the field of visual reconstruction.